Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
FK3311 is a cell permeable and orally available sulfonanilide that acts as a COX-2 inhibitor and non-steroidal anti-inflammatory drug (NSAID).1,2 FK3311 inhibits LPS-induced thromboxane B2 (TxB2; Item No. 19030) production (IC50 = 316 nM) in vitro and inhibits adjuvant-induced arthritis (ED50 = 0.29 mg/kg) in rats without causing gastrointestinal irritation. FK3311 also alleviates ischemia-repurfusion injury in canine liver and rat lung in vivo.3,4
WARNING This product is not for human or veterinary use.
1. Synthesis and pharmacological properties of 2'-
2. Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDs and Cox 2 inhibitors. Inflamm. Res. 44(6), 253-257 (1995).
3. The effect of cyclooxygenase-
4. Effects of the COX-